Literature DB >> 3009722

Immunological treatment of multiple sclerosis. II.

R A Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009722     DOI: 10.1007/bf00313848

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  25 in total

1.  Intravenous methylprednisolone for multiple sclerosis in relapse.

Authors:  M P Barnes; D E Bateman; P G Cleland; D J Dick; T J Walls; P K Newman; M Saunders; P J Tilley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

2.  Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis.

Authors:  U Jahnke; E H Fischer; E C Alvord
Journal:  Science       Date:  1985-07-19       Impact factor: 47.728

3.  An assessment of plasma exchange in progressive multiple sclerosis.

Authors:  H L Weiner
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

4.  Systemic alpha-interferon therapy of multiple sclerosis.

Authors:  R L Knobler; H S Panitch; S L Braheny; J C Sipe; G P Rice; J R Huddlestone; G S Francis; C K Hooper; R M Kamin-Lewis; K P Johnson
Journal:  Neurology       Date:  1984-10       Impact factor: 9.910

5.  Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.

Authors:  R S Tindall; J E Walker; A L Ehle; L Near; J Rollins; D Becker
Journal:  Neurology       Date:  1982-07       Impact factor: 9.910

6.  Acute and long-term complications of corticosteroid pulse therapy.

Authors:  F A Wollheim
Journal:  Scand J Rheumatol Suppl       Date:  1984

7.  Hyperbaric oxygen and multiple sclerosis: short-term results of a placebo-controlled, double-blind trial.

Authors:  M P Barnes; D Bates; N E Cartlidge; J M French; D A Shaw
Journal:  Lancet       Date:  1985-02-09       Impact factor: 79.321

8.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

9.  "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.

Authors:  G Abbruzzese; C Gandolfo; C Loeb
Journal:  Ital J Neurol Sci       Date:  1983-06

10.  Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children.

Authors:  N Orta-Sibu; C Chantler; M Bewick; G Haycock
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24
View more
  3 in total

1.  A 10-year matched-pairs study comparing azathioprine and no immunosuppression in multiple sclerosis.

Authors:  L Kappos; R Heun; H G Mertens
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

2.  Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.

Authors:  I Wirguin; E Shinar; O Abramsky
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

3.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.